Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Stem Cell Therapy International Engages the Cutler Law Group.


TAMPA, Fla. -- Stem Cell Therapy stem cell therapy Cell therapy Molecular medicine A technology in which a person's own cells–eg, neuronal stem cells are triggered to revert to their primitive embryonic form, then redifferentiate into mature cells of various organs  International, Inc., (ATYD), a company in the field of regenerative medicine that specializes in the treatment of patients with stem cell transplantation Stem Cell Transplantation Definition

Stem cells are basic human cells that reproduce (replicate) easily, providing a continuous source of new, sometimes different types of cells.
 therapy as well as being a global supplier of biological solutions containing new lines of stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 products, has retained the services of the Augusta, Georgia-based Cutler Law Group (http://www.cutlerlaw.com), a firm specializing in national and international securities law transactions.

Chief Executive Officer Calvin Cao of Stem Cell Therapy International, Inc., said, "We have retained the legal counsel of the Cutler Law Group to insure that we are in compliance with applicable securities laws and regulations."

Stem cell transplantation therapy is a field of medicine, which uses techniques and technologies that rely on replacing diseased, damaged or dysfunctional cells with healthy, functioning ones. This therapy is similar to the process of organ transplantation The transfer of organs such as the kidneys, heart, or liver from one body to another.

The transplantation of human organs has become a common medical procedure. Typical organs transplanted are the kidneys, heart, liver, pancreas, cornea, skin, bones, and lungs.
, only the treatment consists of the transplantation of stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young  into the body rather than entire organs, thus eliminating any chance of rejection or the need for immunosuppression immunosuppression

Suppression of immunity with drugs, usually to prevent rejection of an organ transplant. Its aim is to allow the recipient to accept the organ permanently with no unpleasant side effects.
 drugs. These new techniques are being applied to finding a cure for a wide range of human disorders, including neurological diseases such as Alzheimer's, Parkinson's Disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. , ALS Als (äls), Ger. Alsen, island, 121 sq mi (313 sq km), Sønderjylland co., S Denmark, in the Lille Bælt, separated from the mainland by the narrow Alensund.  (Lou Gehrig's disease Lou Geh·rig's disease
n.
See amyotrophic lateral sclerosis.
), leukemia, muscular dystrophy, multiple sclerosis, arthritis, spinal cord injuries, brain injury, stroke, heart disease, liver and retinal disease, diabetes as well as certain types of cancer and the side effects of chemotherapy.

With the enactment of Proposition 71 in California in November 2004, a fund of $3 billion was created to fund stem cell research. Since then three other states New Jersey, Connecticut and Illinois, have allocated funds for stem cell research. Among the leading public companies in the U.S. in the field of stem cell technology are A.C.T. Holdings, Inc.; ViaCell; Geron; StemCells, Inc., and Aastrom Biosciences Inc. For additional information, please visit our website @ www.scticorp.com.

About Stem Cell Therapy International (SCTI SCTI Stanford Center for Technology and Innovation
SCTI Sodium Components Test Installation
SCTI Southern California Transplantation Institute (and Liver Center)
SCTI Small Component Test Installation
)

Stem Cell Therapy International, Inc. (SCTI) is in the field of regenerative medicine. SCTI provides new stem cell solutions, which are being used in the treatment of patients suffering from degenerative disorders of the human body. SCTI operates in conjunction with advanced medical facilities devoted to the treatment of human physical disorders with stem cell transplantation therapy. The company intends to continue to establish relationships with highly specialized, professional medical treatment centers outside of the United States that will treat patients with the stem cell transplantation therapy. In addition, SCTI intends to provide biological solutions containing new stem cell products in the United States to universities, institutes and privately funded laboratory facilities for research purposes and clinical trials.

About the Cutler Law Group

Cutler Law Group has substantial experience in all areas of SEC, stock exchange and state securities law practice. Our contact base provides opportunities for attracting investment capital to your company and for completing appropriate compliance with applicable securities laws and regulations. Our client base includes many public companies, broker dealers, underwriters, investment advisors, financial consultants, entities seeking growth capital and many others.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 22, 2005
Words:504
Previous Article:Bear Stearns Continues to Build Global Prime Brokerage Sales Effort; Additional Staff in London Enhance Service Capabilities for Hedge Funds.
Next Article:Bioenvision to Hold Fiscal 2005 Year-End Financial Results Conference Call Tuesday, September 27, 2005.



Related Articles
Attack of the clones: as cloning technology marches forward, state legislatures are faced with some hard decisions.
Stem Cell Therapy International Sponsors Tech Council of Maryland's 'The Business of Stem Cell Research Conference'.
RENEURON REPORTS REN004 DATA PROMISING FOR PARKINSON'S.
Have stem cells finally arrived? Despite fraud and controversy, signs point to an emerging, money-making industry.
Stelic Announces Research Activities, Business Strategy for the Current Fiscal Year.
Ex-IRS official challenges Missouri bishops' election pressure.
CyGenics Selected In Top 3 Asian Technology Pioneers by World Economic Forum.
Female stem cells flourish: sex difference could affect therapies.
Stem cells & MS: what the investigators see.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles